Equifax Inc. (EFX) shares fell 3.4% to $140.83 as of September 29, 2026, a moderate decline from the prior close of $145.78. BestStocks flagged the session as a major change for EFX. Below, we break down what changed for EFX, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
What happened
EFX fell 3.4% to $140.83
Equifax shares fell 6.4% on September 4, 2026, driven by regulatory and industry pressures on credit reporting agencies, concerns over potential shifts in mortgage credit reporting standards (including bi-merge reporting transitions), and recent insider selling by company executives. The decline occurred amid broader market caution and sector-wide scrutiny of commercial service providers.
For Equifax Inc. investors, the recent signals add up to a bearish shift. On the constructive side: Positive price momentum; Positive price momentum. Weighing against that: Material negative event; Negative session, down 3.4%. Wall Street's consensus price target sits at $215.00, implying +52.7% upside from $140.83. Over the past 90 days analysts logged 1 upgrade and 0 downgrades. BestStocks rates the overall signal quality low (57/100). With earnings roughly 21 days out, the next report is the most likely near-term test of the move.
EFX price reaction
EFX last traded at $140.83, down $4.95 (-3.40%) from the previous close of $145.78. The session traded on 1.7× average volume (above avg), so the move carried above-average conviction. Over the past month the stock has ranged between $140.83 and $189.16, and it currently sits about 0% of the way up that band.
Bullish and bearish analyst opinions on Equifax Inc. (EFX)
▼Latest catalyst·a bearish counterpoint
The latest catalyst — a flagged risk event — a bearish counterpoint that challenges the prevailing bullish analyst view.
The consensus analyst price target on Equifax Inc. (EFX) is $215.00, 52.7% above the recent $140.83. Over the past 90 days analysts logged 1 upgrade, 11 maintains, and 0 downgrades. Here is how the bullish and bearish cases on EFX line up.
▲ The bullish case
+Wall Street's consensus price target of $215.00 implies +52.7% upside from $140.83.
+The Street's most bullish target is $245.00 (+74.0%).
+1 analyst upgrade in the past 90 days, most recently Rothschild & Co to Buy (2026-08-21).
+Positive price momentum.
▼ The bearish case
−Material negative event.
−Negative session, down 3.4%.
−Equifax Inc. moved -4.47% intraday from $145.78 to $139.27.
−Equifax filed a material event on Form 8-K today, triggering a 6.89% intraday decline to $174.16.
−Equifax stock fell 6.08% to $169.13 following the company's July 21 earnings report, which beat Q2 expectations (EPS $2.25 vs. $2.21 consensus) but issued downbeat full-year guidance of $6.71B–$6.78B, well below Wall Street's $7.39B consensus (PRNewswire).
Bull vs bear balanceBearish Shift
BearishNeutralBullish
The latest catalyst moved the balance toward the bears — the hollow tick marks where it sat before.
Weighing both sides, BestStocks' composite read of recent signals is bearish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Sep 29, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Equifax Inc. moved -4.46% intraday from $155.32 to $148.39. Equifax (EFX ) shares are seeing continued downward pressure amid a broader multi-week slide. ### 📉 Main Pressures - Regulatory Overhang: FHFA scrutiny over credit bureau pricing and potential shifts to bi-merge standards. - Settlement Impact: Ongoing digestion of the recent $100 million credit score error class-action settlement. - Macro Headwinds: Persistent high mortgage rates slowing down key lending volumes. If you're looking at your portfolio, do you currently own EFX or are you considering buying the dip?
Equifax Inc. moved -2.29% intraday from $159.78 to $156.12. Equifax Inc. (EFX ) is down about 2.2% to $156.20 on September 23, 2026, underperforming despite announcing new product rollouts. ### 📉 Catalysts & Market Pressures - Product Announcements: Launched new fraud detection and healthcare credentialing tools, though failing to spark an immediate upside. - Lingering Overhangs: Continued investor caution regarding recent litigation, regulatory scrutiny, and a $100 million credit-score error settlement. - Valuation & Sector Trends: Trading near lower bounds relative to its 52-week range amid broader professional services and credit-market sensitivity. If you're evaluating a position, would you like to review: - Current analyst consensus price targets - Key fundamental metrics (P/E ratio, debt load)
Material / Earnings2026-09-22+0.7%
EFX moved -100.00% from its $160.44 open to a $159.78 close on 2026-09-22.
Material / Earnings2026-09-17-1.6%
Equifax Inc. (EFX) moved -2.43% from $165.18 to $161.17 on 2026-09-17, reaching a new 30-day low. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The decline occurred on volume near its 5-day average.
EFX fell 2.50% to $167.99, driven by persistent headwinds in the mortgage and housing markets. Management addressed investors at the Barclays Global Financial Services Conference on September 14, acknowledging structural pressure and a slow environment in the housing sector (investing.com). The decline reflects ongoing valuation adjustments in the credit services space amid broader macro caution rather than a discrete negative event.
Equifax shares declined 2.43% to $172.74 amid ongoing regulatory scrutiny and mortgage-market headwinds affecting the credit reporting sector. Per web sources cited by Google's AI Overview (MarketWatch, Yahoo Finance), concerns over potential bi-merge credit reporting changes, heightened regulatory oversight, and macro uncertainty in housing and lending markets are pressuring sentiment. Volume of 217,499 shares is running 1.15x normal for this stage of the session.
Equifax shares fell 5.94% to $177.85 amid a broader market retreat driven by profit-taking, rising Treasury yields (10-year climbing past 4.2%), and caution ahead of economic data, per web sources. The decline occurred on elevated volume of 3.26x the time-adjusted average, reflecting sector-wide pressure on equities alongside lingering investor scrutiny of the company's valuation following its $100 million settlement over credit score errors.
Material / Earnings2026-09-04-6.4%
Equifax Inc. (EFX) moved +4.92% from $168.75 to $177.05 on 2026-09-04 on elevated volume (3.3x the 5-day average). We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found. The move occurred as broader market indices fell due to profit-taking and rising Treasury yields (10-year yield above 4.2%), suggesting EFX's gain was driven by relative strength or sector rotation rather than company-specific news.
In-depth EFX event analyses
Permanent, dated analyses of EFX's most significant sessions.
Equifax shares fell 6.4% on September 4, 2026, driven by regulatory and industry pressures on credit reporting agencies, concerns over potential shifts in mortgage credit reporting standards (including bi-merge reporting transitions), and recent insider selling by company executives. The decline occurred amid broader market caution and sector-wide scrutiny of commercial service providers.
How much did EFX stock fall?
EFX lost 3.40% ($4.95) versus the prior close of $145.78, last trading at $140.83 on 1.7× average volume.
When is Equifax Inc.'s next earnings date?
EFX's next earnings report is estimated for 2026-10-20 — about 21 days away.
What is the analyst price target for EFX?
The consensus analyst price target for EFX is $215.00, about 52.7% above the current $140.83. Over the past 90 days, analysts recorded 1 upgrade, 11 maintains, and 0 downgrades.
How BestStocks tracks EFX
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared EFX-specific materiality thresholds, triggering an evidence check. It draws on 20 tracked change events for EFX, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of September 29, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.
